Literature DB >> 35142896

Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study.

Federico Angriman1,2,3, Laura C Rosella4,5,6,7, Patrick R Lawler8,9, Dennis T Ko5,10, Hannah Wunsch11,8,12,5, Damon C Scales11,8,12,5.   

Abstract

PURPOSE: To determine whether surviving a first sepsis hospitalization is associated with long-term cardiovascular events.
METHODS: Population-based matched cohort study conducted in Ontario, Canada (2008-2017). Adult survivors (older than 18 years) of a first sepsis hospitalization were matched to adult survivors of a non-sepsis hospitalization using hard-matching and propensity score methods. Patients with pre-existing cardiovascular disease were excluded. The primary composite outcome was myocardial infarction, stroke, or cardiovascular death up to 5 years of follow-up. Secondary outcomes included venous thromboembolism and all-cause death. Cox proportional hazards models with robust standard errors were used to estimate the association of sepsis with all outcomes of interest; hazard ratios (HR) and 95% confidence intervals (CI) were calculated. Sensitivity analyses included Fine and Gray models to account for the competing risk of all-cause death and probabilistic bias analyses.
RESULTS: 254,241 adult sepsis survivors were matched to adult survivors of non-sepsis hospitalization episodes. Sepsis survivors experienced an increased hazard of major cardiovascular events compared to non-sepsis survivors (HR 1.30; 95% CI 1.27-1.32), which was more pronounced in younger patients (HR 1.66; 95% CI 1.36-2.02 for patients aged 40 or younger; HR 1.21; 95% CI 1.18-1.24 for patients older than 80 years). Sepsis survivors also faced an increased hazard of venous thromboembolism (HR 1.61; 95% CI 1.55-1.67) and all-cause death (HR 1.26; 95% CI 1.25-1.27). Sensitivity analyses yielded consistent results.
CONCLUSIONS: Adult sepsis survivors experience an increased hazard of major cardiovascular events compared to survivors of a non-sepsis hospitalization.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cardiovascular disease; Myocardial infarction; Sepsis; Sepsis survivors; Stroke; Venous thromboembolic disease

Mesh:

Year:  2022        PMID: 35142896     DOI: 10.1007/s00134-022-06634-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   41.787


  41 in total

1.  Post-Acute Care Use and Hospital Readmission after Sepsis.

Authors:  Tiffanie K Jones; Barry D Fuchs; Dylan S Small; Scott D Halpern; Asaf Hanish; Craig A Umscheid; Charles A Baillie; Meeta Prasad Kerlin; David F Gaieski; Mark E Mikkelsen
Journal:  Ann Am Thorac Soc       Date:  2015-06

2.  Sepsis-Associated Mortality, Resource Use, and Healthcare Costs: A Propensity-Matched Cohort Study.

Authors:  Kelly Farrah; Lauralyn McIntyre; Christopher J Doig; Robert Talarico; Monica Taljaard; Murray Krahn; Dean Fergusson; Alan J Forster; Doug Coyle; Kednapa Thavorn
Journal:  Crit Care Med       Date:  2021-02-01       Impact factor: 7.598

Review 3.  Enhancing Recovery From Sepsis: A Review.

Authors:  Hallie C Prescott; Derek C Angus
Journal:  JAMA       Date:  2018-01-02       Impact factor: 56.272

4.  Time to Treatment and Mortality during Mandated Emergency Care for Sepsis.

Authors:  Christopher W Seymour; Foster Gesten; Hallie C Prescott; Marcus E Friedrich; Theodore J Iwashyna; Gary S Phillips; Stanley Lemeshow; Tiffany Osborn; Kathleen M Terry; Mitchell M Levy
Journal:  N Engl J Med       Date:  2017-05-21       Impact factor: 91.245

5.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

Review 6.  Understanding Long-Term Outcomes Following Sepsis: Implications and Challenges.

Authors:  Manu Shankar-Hari; Gordon D Rubenfeld
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

7.  Risk Factors at Index Hospitalization Associated With Longer-term Mortality in Adult Sepsis Survivors.

Authors:  Manu Shankar-Hari; David A Harrison; Paloma Ferrando-Vivas; Gordon D Rubenfeld; Kathryn Rowan
Journal:  JAMA Netw Open       Date:  2019-05-03

8.  Increased 1-year healthcare use in survivors of severe sepsis.

Authors:  Hallie C Prescott; Kenneth M Langa; Vincent Liu; Gabriel J Escobar; Theodore J Iwashyna
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 30.528

Review 9.  Rate and risk factors for rehospitalisation in sepsis survivors: systematic review and meta-analysis.

Authors:  Manu Shankar-Hari; Rohit Saha; Julie Wilson; Hallie C Prescott; David Harrison; Kathryn Rowan; Gordon D Rubenfeld; Neill K J Adhikari
Journal:  Intensive Care Med       Date:  2020-01-23       Impact factor: 17.440

10.  Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.

Authors:  Kristina E Rudd; Sarah Charlotte Johnson; Kareha M Agesa; Katya Anne Shackelford; Derrick Tsoi; Daniel Rhodes Kievlan; Danny V Colombara; Kevin S Ikuta; Niranjan Kissoon; Simon Finfer; Carolin Fleischmann-Struzek; Flavia R Machado; Konrad K Reinhart; Kathryn Rowan; Christopher W Seymour; R Scott Watson; T Eoin West; Fatima Marinho; Simon I Hay; Rafael Lozano; Alan D Lopez; Derek C Angus; Christopher J L Murray; Mohsen Naghavi
Journal:  Lancet       Date:  2020-01-18       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.